Orchestra BioMed Holdings, Inc. (OBIO)
USD 4.76
(-3.64%)
USD 4.76
(-3.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -46.12 Million | -29.28 Million | -19.42 Million | -26.18 Million |
| Net Income | -49.12 Million | -33.6 Million | -23.01 Million | -21.35 Million |
| Depreciation & Amortization | 287 Thousand | 222 Thousand | 181 Thousand | 137 Thousand |
| Deferred income taxes | -8.07 Million | -3.63 Million | 288 Thousand | - |
| Stock-based compensation | 7.62 Million | 3.41 Million | 302 Thousand | 221 Thousand |
| Change in working capital | -3.3 Million | -451 Thousand | 2.59 Million | -8.12 Million |
| Other non-cash items | 6.45 Million | 4.77 Million | 217 Thousand | 2.93 Million |
| Investing Cash Flow | 10.68 Million | -64.12 Million | 13.01 Million | 26.96 Million |
| Investments in PPE | -78 Thousand | -591 Thousand | -274 Thousand | -539 Thousand |
| Acquisitions | -10.76 Million | -29.06 Million | -13.29 Million | -27.5 Million |
| Investment purchases | -142.03 Million | -63.53 Million | -213 Thousand | -15.62 Million |
| Sales/Maturities of investments | 152.79 Million | 92.59 Million | 13.5 Million | 43.12 Million |
| Other Investing Activities | 10.76 Million | -63.53 Million | 13.29 Million | 27.5 Million |
| Financing Cash Flow | 46.21 Million | 103.25 Million | -3.99 Million | 10 Million |
| Debt repayment | -10.84 Million | -3.55 Million | -4 Million | -10 Million |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | -92.59 Million | - | - |
| Common Stock Issuance | 254 Thousand | 190 Thousand | - | 162.28 Million |
| Other Financing Activities | 56.81 Million | 99.51 Million | 7000.00 | -152.28 Million |
| Accounts receivables | -3000.00 | 25 Thousand | 47 Thousand | -79 Thousand |
| Accounts payables | 145 Thousand | 183 Thousand | 1.07 Million | -2.6 Million |
| Inventory | 131 Thousand | -208 Thousand | 1000.00 | -26 Thousand |
| Other working capital | -3.58 Million | -451 Thousand | 1.47 Million | -5.4 Million |
| Cash at beginning of period | 19.78 Million | 1.75 Million | 20.34 Million | 9.56 Million |
| Cash at end of period | 30.55 Million | 19.78 Million | 9.93 Million | 20.34 Million |
| Capital Expenditure | -78 Thousand | -591 Thousand | -274 Thousand | -539 Thousand |
| Effect of forex changes on cash | - | 11.42 Million | - | - |
| Net cash flow / Change in cash | 10.77 Million | 18.02 Million | -10.4 Million | 10.78 Million |
| Free Cash Flow | -46.2 Million | -29.88 Million | -19.7 Million | -26.72 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -15.98 Million | -13.46 Million | -12.81 Million | -49.12 Million | -13.31 Million | -12.04 Million |
| Depreciation & Amortization | 74 Thousand | 74 Thousand | 72 Thousand | 287 Thousand | 71 Thousand | 73 Thousand |
| Deferred income taxes | - | - | -1.08 Million | -8.07 Million | -293 Thousand | 31 Thousand |
| Stock-based compensation | 2.76 Million | 2.58 Million | 919 Thousand | 7.62 Million | 3.51 Million | 1.7 Million |
| Change in working capital | 3.07 Million | -1.83 Million | -116 Thousand | -3.3 Million | 613 Thousand | 612 Thousand |
| Other non-cash items | 2.74 Million | 2.19 Million | 2.05 Million | 6.45 Million | -867 Thousand | -867 Thousand |
| Investing Cash Flow | 10.42 Million | 5.86 Million | 33.15 Million | 10.68 Million | 12.94 Million | 8.11 Million |
| Investments in PPE | -107 Thousand | -8000.00 | 3000.00 | -78 Thousand | -19 Thousand | -27 Thousand |
| Acquisitions | - | - | -33.14 Million | -10.76 Million | -12.96 Million | -64.2 Million |
| Investment purchases | -18.65 Million | -23.73 Million | -3.95 Million | -142.03 Million | -38.52 Million | -56.05 Million |
| Sales/Maturities of investments | 29.18 Million | 29.6 Million | 37.1 Million | 152.79 Million | 51.49 Million | 64.2 Million |
| Other Investing Activities | 10.53 Million | 5.86 Million | 33.14 Million | 10.76 Million | 12.96 Million | 64.2 Million |
| Financing Cash Flow | 171 Thousand | 18 Thousand | -10.69 Million | 46.21 Million | 4000.00 | 86 Thousand |
| Debt repayment | - | - | -10.84 Million | -10.84 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 171 Thousand | 18 Thousand | 153 Thousand | 254 Thousand | 4000.00 | 86 Thousand |
| Other Financing Activities | 171 Thousand | 18 Thousand | -10.69 Million | 56.81 Million | 4000.00 | 86 Thousand |
| Accounts receivables | -13 Thousand | 32 Thousand | -13 Thousand | -3000.00 | 85 Thousand | -95 Thousand |
| Accounts payables | - | -1.27 Million | 1.46 Million | 145 Thousand | 758 Thousand | 1.38 Million |
| Inventory | 45 Thousand | 31 Thousand | -8000.00 | 131 Thousand | 41 Thousand | 54 Thousand |
| Other working capital | 3.03 Million | -1.89 Million | -95 Thousand | -3.58 Million | -271 Thousand | -728 Thousand |
| Cash at beginning of period | 23.32 Million | 30.55 Million | 19.07 Million | 19.78 Million | 16.4 Million | 18.69 Million |
| Cash at end of period | 23.71 Million | 23.32 Million | 30.55 Million | 30.55 Million | 19.07 Million | 16.4 Million |
| Capital Expenditure | -107 Thousand | -8000.00 | 3000.00 | -78 Thousand | -19 Thousand | -27 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 389 Thousand | -7.23 Million | 11.48 Million | 10.77 Million | 2.66 Million | -2.28 Million |
| Free Cash Flow | -10.31 Million | -13.12 Million | -10.97 Million | -46.2 Million | -10.3 Million | -10.51 Million |
MDPR
DIANATEA
ZDGGF
PX
SABTNL
183490